This inventor holds 28 USPTO granted patents and 6 published patent applications and 5 EPO patents, primarily in Semiconductor Devices. Top assignees: Hitachi, Ltd., Murata Manufacturing Co., Ltd., Hitachi Microcomputer Engineering, Ltd.. Active years: 1978-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hinodemachi, JA (1978)
- Hinodemachi, JP (1982)
- Nagaokakyo, JP (1986)
- Kyoto, JP (1990)
- Machida, JP (1993 - 1994)
- Hitachi, JP (1998)
- Hakui, JP (2000 - 2003)
- Hitachinaka, JP (2014)
- Tokyo, JP (1980 - 2021)
Company Filing History:
15 out of 42,743 
7 out of 13,796 
3 out of 149 
Years Active: 1978-2021
Areas of Expertise:
Title: Satoru Ito: A Pioneer in Immuno-Oncology
Introduction
Satoru Ito, based in Tokyo, Japan, is an esteemed inventor with an impressive portfolio of 28 patents. His groundbreaking work primarily focuses on immuno-oncology, particularly in the development of methods to enhance the efficacy and safety of cancer therapies. His innovative approaches have laid significant groundwork in the field, especially concerning immune checkpoint inhibitors.
Latest Patents
Satoru Ito's recent patents showcase his commitment to advancing cancer treatment methodologies. One notable patent is a "Method for Reducing Side Effects of Immune Checkpoint Control Agent," which introduces a side-effect reducing agent composed of an anti-CD4 antibody exhibiting high cytotoxic activity. This invention aims to mitigate the adverse effects commonly associated with immune checkpoint regulators used in cancer therapies, such as anti-PD-L1 and anti-CTLA-4 antibodies.
Another significant patent by Ito, titled "Method for Assessing Therapeutic Effect of Anti-Cancer Agent Having Anti-CD4 Antibody as Active Ingredient," presents a systematic approach for monitoring the anticancer effects of drugs targeting immune checkpoints. This method involves analyzing the expression of specific immune checkpoint receptors and cell surface molecules on T cells to evaluate the therapeutic efficacy of the treatments.
Career Highlights
Throughout his career, Satoru Ito has made remarkable contributions while working with notable companies, including Hitachi, Ltd. and Murata Manufacturing Co., Ltd. His experiences in these esteemed organizations have undoubtedly shaped his innovative approach to solving complex problems in the medical field.
Collaborations
Ito has collaborated with several talented individuals, including Yuji Hara and Tatsuro Toya. These teamwork dynamics have allowed for the exchange of ideas and fostering innovation in their projects, ultimately leading to advancements in cancer treatment methodologies.
Conclusion
Satoru Ito stands as a prominent figure in the realm of immuno-oncology with his extensive patent portfolio and collaborative efforts. His dedication to reducing side effects and improving the assessment of cancer therapies marks a significant milestone in the ongoing battle against cancer. As he continues to innovate, the impact of his work will undoubtedly resonate within the medical community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile